{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:39:15Z","timestamp":1792067955606,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["1K08HS025701"],"award-info":[{"award-number":["1K08HS025701"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1K08DA045933-01"],"award-info":[{"award-number":["1K08DA045933-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL155895"],"award-info":[{"award-number":["K23HL155895"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annemergmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.annemergmed.2023.11.020","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T11:36:26Z","timestamp":1704281786000},"page":"340-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2292-045X","authenticated-orcid":false,"given":"Lauren M.","family":"Westafer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caty","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Potee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Schoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2023.11.020_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.annemergmed.2021.10.005","article-title":"Naloxone and buprenorphine prescribing following US emergency department visits for suspected opioid overdose: August 2019 to April 2021","volume":"79","author":"Chua","year":"2022","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/acem.14369","article-title":"\u2018This is part of emergency medicine now\u2019: a qualitative assessment of emergency clinicians\u2019 facilitators of and barriers to initiating buprenorphine","volume":"29","author":"Schoenfeld","year":"2022","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.annemergmed.2021.05.024","article-title":"Rapid adoption of low-threshold buprenorphine treatment at California emergency departments participating in the CA bridge program","volume":"78","author":"Snyder","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.annemergmed.2021.10.012","article-title":"Sustained implementation of a multicomponent strategy to increase emergency department-initiated interventions for opioid use disorder","volume":"79","author":"Lowenstein","year":"2022","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am J Public Health"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib6","article-title":"Geographic trends, patient characteristics, and outcomes of infective endocarditis associated with drug abuse in the United States from 2002 to 2016","volume":"8","author":"Kadri","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/acem.14507","article-title":"\u2018Just give them a choice\u2019: patients\u2019 perspectives on starting medications for opioid use disorder in the ED","volume":"29","author":"Schoenfeld","year":"2022","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib10","series-title":"Proceedings of the 4th International Conference on Persuasive Technology\u2014Persuasive 2009","first-page":"1","article-title":"A\u00a0behavior model for persuasive design","author":"Fogg","year":"2009"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib11","series-title":"Thematic Analysis: A Practical Guide","author":"Braun","year":"2021"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib12","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample size in qualitative interview studies: guided by information power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qual Health Res"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103348","article-title":"\u2018I\u2019m pretty sure it\u2019s either food poisoning or Covid-19\u2019: lived experience versus medical knowledge in diagnosing substance use problems","volume":"98","author":"Frank","year":"2021","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","article-title":"Understanding why patients with substance use disorders leave the hospital against medical advice: a qualitative study","volume":"41","author":"Simon","year":"2020","journal-title":"Subst Abus"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib15","author":"Bromley"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12954-018-0276-0","article-title":"Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study","volume":"16","author":"Goldman","year":"2019","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugpo.2018.04.017","article-title":"Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: do we know enough to promote it?","volume":"58","author":"McGowan","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13722-023-00395-w","article-title":"\u2018I wouldn\u2019t need Narcan for myself, but I can have it for somebody else:\u2019 perceptions of harm reduction among hospitalized patients with OUD","volume":"18","author":"French","year":"2023","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib19","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.3390\/ijerph18126231","article-title":"Pharmacy technicians, stigma, and compassion fatigue: front-line perspectives of pharmacy and the US opioid epidemic","volume":"18","author":"Cernasev","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib20","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1080\/10826084.2022.2091786","article-title":"Types and sources of stigma on opioid use treatment and recovery communities on Reddit","volume":"57","author":"Kepner","year":"2022","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/08897077.2021.1900988","article-title":"Pharmacists\u2019 stigma toward patients engaged in opioid misuse: when \u201csocial distance\u201d does not mean disease prevention","volume":"42","author":"Werremeyer","year":"2021","journal-title":"Subst Abus"},{"key":"10.1016\/j.annemergmed.2023.11.020_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajem.2021.03.056","article-title":"Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal","volume":"47","author":"Kilaru","year":"2021","journal-title":"Am J Emerg Med"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064423014142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064423014142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:50:04Z","timestamp":1759294204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064423014142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0196064423014142"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2023.11.020","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2023.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Emergency Physicians.","name":"copyright","label":"Copyright"}]}}